Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

IMTOZ trial findings and subsequent approval of Isa-VRd regimen for transplant-ineligible myeloma suggested the combo as a ...

Recordati 's (BIT: RECI) shares jumped on Friday following its deal with Sanofi (EPA: SASY) (NASDAQ: SNY) to buy the global ...

In a phase 3 trial, tolebrutinib has a significant effect on slowing disability progression in some patients with multiple sclerosis..

Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting ...